Metabolic Effects of Furosemide +HSS in Refractory Ascites

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

April 30, 2016

Conditions
AscitesCirrhosis
Interventions
DRUG

intravenous furosemide

treatment with intravenous infusion of furosemide (doses 125-250mg⁄ bid) plus small volumes of HSS (150mL 1.4-4.6% NaCl), from the first day after admission until 3 days before discharge, with water restriction and a normal sodium diet.

DRUG

Hypertonic saline solutions

Intravenous small volumes of HSS (150mL 1.4-4.6% NaCl), plus treatment with intravenous infusion of furosemide (doses 125-250mg⁄ bid) from the first day after admission until 3 days before discharge, with water restriction and a normal sodium diet.

PROCEDURE

Seriated paracentesis

repeated paracentesis from the first day after admission until 3 days before discharge

Trial Locations (3)

90127

Antonino Tuttolomondo, Palermo

Internal Medicine Ward of Palermo University Hospital, Palermo

Internal Medicine Ward, University of Palermo, Palermo

All Listed Sponsors
lead

University of Palermo

OTHER

NCT02821377 - Metabolic Effects of Furosemide +HSS in Refractory Ascites | Biotech Hunter | Biotech Hunter